| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/20/2012 | US20120237475 Novel Inhibitors |
| 09/20/2012 | US20120237474 Fluorinated diaryl urea derivatives |
| 09/20/2012 | US20120237448 Sphingosine kinase type 1 inhibitors, and processes for using same |
| 09/20/2012 | US20120237442 Design and Construction of Novel Multivalent Antibodies |
| 09/20/2012 | US20120237441 Enhanced b cell cytotoxicity of cdim binding antibody |
| 09/20/2012 | DE102010018961B4 Genetisch modifiziertes Paramyxovirus zur Behandlung von Tumorerkrankungen Genetically modified Paramyxovirus in the treatment of tumor diseases |
| 09/20/2012 | CA2835475A1 Yeast-brachyury immunotherapeutic compositions |
| 09/20/2012 | CA2830503A1 Method for making pluripotent stem cells |
| 09/20/2012 | CA2830240A1 Methods of treating breast cancer with anthracycline therapy |
| 09/20/2012 | CA2830195A1 Combination of anti-clusterin oligonucleotide with hsp90 inhibitor for the treatment of prostate cancer |
| 09/20/2012 | CA2830191A1 Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer |
| 09/20/2012 | CA2830143A1 Pyrrolopyridineamino derivatives as mps1 inhibitors |
| 09/20/2012 | CA2830131A1 Imidazo pyrazines |
| 09/20/2012 | CA2829998A1 Substituted diphenyl derivatives |
| 09/20/2012 | CA2829963A1 Human tissue factor antibody and uses thereof |
| 09/20/2012 | CA2829736A1 N-carboxyalkylauristatins and use thereof |
| 09/20/2012 | CA2829592A1 Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione |
| 09/20/2012 | CA2829570A1 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
| 09/20/2012 | CA2829096A1 Combination therapies for hematologic malignancies |
| 09/20/2012 | CA2829088A1 Piperazinedione compounds |
| 09/20/2012 | CA2828616A1 Uses of modified elr-cxc chemokine g31p to treat cancer |
| 09/20/2012 | CA2828075A1 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers |
| 09/20/2012 | CA2827161A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| 09/19/2012 | EP2500362A2 Humanized antibodies against TL1A |
| 09/19/2012 | EP2500063A1 Combination therapy using HDAC inhibitors and melphalan for treating cancer |
| 09/19/2012 | EP2500036A1 MET inhibitors for enhancing radiotherapy efficacy |
| 09/19/2012 | EP2500035A1 Pharmaceutical formulation containing immunglobulin |
| 09/19/2012 | EP2499247A2 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 09/19/2012 | EP2499163A1 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein |
| 09/19/2012 | EP2499161A1 Antibodies specific for claudin 6 (cldn6) |
| 09/19/2012 | EP2499153A1 Tubulin inhibitors |
| 09/19/2012 | EP2499151A2 Mammalian metabolites of steroids |
| 09/19/2012 | EP2499145A2 Spiro-oxindole mdm2 antagonists |
| 09/19/2012 | EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 09/19/2012 | EP2499143A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use |
| 09/19/2012 | EP2499138A1 Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof |
| 09/19/2012 | EP2499129A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 09/19/2012 | EP2499128A1 Crystalline cdc7 inhibitor salts |
| 09/19/2012 | EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 09/19/2012 | EP2499124A1 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 09/19/2012 | EP2499117A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 09/19/2012 | EP2499116A1 Sorafenib ethylsulfonate salt, process for preparation and use |
| 09/19/2012 | EP2499114A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
| 09/19/2012 | EP2499113A1 Homoglutamic acid derivatives |
| 09/19/2012 | EP2498821A1 Anti integrin antibodies linked to nanoparticles loaded with chemotherapeutic agents |
| 09/19/2012 | EP2498808A2 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 09/19/2012 | EP2498799A1 Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2 |
| 09/19/2012 | EP2498795A2 Granulysin in immunotherapy |
| 09/19/2012 | EP2498793A1 Use of peptide epoxyketones for metastasis suppression |
| 09/19/2012 | EP2498785A1 Use of synergistic combinations of an avermectin and an antineoplastic compounds for the treatment of hematological malignancies |
| 09/19/2012 | EP2498778A1 Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
| 09/19/2012 | EP2498773A2 Compositions for the treatment of chemoresistant leukaemia and/or of potentially chemoresistant leukaemia |
| 09/19/2012 | EP1666481B1 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |
| 09/19/2012 | CN202437739U Herba sarcandrae soft capsule |
| 09/19/2012 | CN1839892B Preparation method of yeast W.domercqiaeY2A variation waufa glucolipid crude extract with antineoplastic activity |
| 09/19/2012 | CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 09/19/2012 | CN102686600A Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| 09/19/2012 | CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors |
| 09/19/2012 | CN102686577A Compounds as tyrosine kinase modulators |
| 09/19/2012 | CN102686279A 载体组合物 Carrier composition |
| 09/19/2012 | CN102686243A Polymeric systems for the delivery of anticancer agents |
| 09/19/2012 | CN102676518A Novel anti-tumor amiRNA (artificial micro Ribonucleic Acid) sequence and application thereof |
| 09/19/2012 | CN102676517A Survivin gene folate receptor targeted novel liposome |
| 09/19/2012 | CN102676516A New use of microRNA 145 |
| 09/19/2012 | CN102676455A Preparation method for dendritic cell of umbilical cord blood source and dendritic cell vaccine |
| 09/19/2012 | CN102676396A Paecilomyces tenuipes strain and application thereof |
| 09/19/2012 | CN102676349A Giant salamander bone healthcare wine and preparation method thereof |
| 09/19/2012 | CN102675655A Water-soluble fullerene and preparation and application methods thereof |
| 09/19/2012 | CN102675482A Method for comprehensively utilizing pear residues |
| 09/19/2012 | CN102675467A Fusion protein of human somatostatin 28 peptide and human serum albumin, encoding gene of fusion protein and preparation method for fusion protein |
| 09/19/2012 | CN102675464A Co-immobilized cytokine, preparation method and applications thereof |
| 09/19/2012 | CN102675462A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 09/19/2012 | CN102675460A Anti-tumor necrosis factor alpha human-derived antibody |
| 09/19/2012 | CN102675449A Deletion form human keratinocyte growth factor-I disulfide bond mutation form and use thereof |
| 09/19/2012 | CN102675431A Antitumor antibiotic gaddie mycin generated by streptosporangium C-3560 |
| 09/19/2012 | CN102675421A Epitope peptide of heat shock protein and application thereof |
| 09/19/2012 | CN102675418A Luteinizing hormone-releasing hormone (LHRH) antagonist derivative, preparation method of LHRH antagonist derivative and application of LHRH antagonist derivative |
| 09/19/2012 | CN102675416A Beta-carboline derivatives, and preparation method and application thereof |
| 09/19/2012 | CN102675406A Ursolic acid nitrogen heterocyclic ring structure modifiers with antitumor activity and preparation method for ursolic acid nitrogen heterocyclic ring structure modifiers |
| 09/19/2012 | CN102675401A Preparation of anti-tumor medicine LQC-Y and application thereof |
| 09/19/2012 | CN102675390A Gemcitabine derivative, preparation method and application thereof |
| 09/19/2012 | CN102675384A Synthesis method of ent-kaurene type glycoside and biological activities thereof |
| 09/19/2012 | CN102675370A Novel compound for curing cancer |
| 09/19/2012 | CN102675330A Furan-flavone compound in arundina graminifolia, preparation method and application |
| 09/19/2012 | CN102675327A Harringtonine alkaloid and preparation method and application thereof |
| 09/19/2012 | CN102675325A Phthalocyanine metal complex containing piperazine ethyoxyl modification group and preparing method thereof |
| 09/19/2012 | CN102675323A Pyrrole-(2, 1-f) (1, 2 and 4) triazine derivative (I) and antitumor effect thereof |
| 09/19/2012 | CN102675311A Fluoro-acrylamide derivative |
| 09/19/2012 | CN102675305A Imidazopyridine compounds, as well as preparation method and application thereof |
| 09/19/2012 | CN102675303A 4-alkyl-2-arylamino-5-(1,2,4-triazole-1-group) thiazole and application thereof to preparation of medicaments for resisting cancer |
| 09/19/2012 | CN102675292A Indolone derivative, medicinal composition thereof and preparation method and application of indolone derivative |
| 09/19/2012 | CN102675289A Novel N-phenyl benzamide derivative serving as protein kinase inhibitor |
| 09/19/2012 | CN102675287A Pharmaceutically acceptable salts of (E)-N-(4-((3-chloro-4-(2-pyridyl methoxy) phenyl) amino)-3-cyano-7-ethyoxyl-6-quinolyl)-3-((2R)-1-methyl pyrrolidine-2-propyl)-2-acrylamide, preparation method and application of salts in medicines |
| 09/19/2012 | CN102675286A Indazoles compound, and preparation method and application thereof, and medical composition |
| 09/19/2012 | CN102675282A Substitutive quinoline compound and application method and uses thereof |
| 09/19/2012 | CN102675281A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 09/19/2012 | CN102675273A 3-aryl-8-allyl-7-hydroxy (methoxyl) coumarin and application in preparation of antitumor drugs |
| 09/19/2012 | CN102675270A Method for extracting anticancer compound from henbane, and application of anticancer compound |
| 09/19/2012 | CN102675258A Novel taxane compound and preparation method thereof |
| 09/19/2012 | CN102675252A Cembrane type diterpenoids with anti-tumor activities and application thereof |